Cite

    Pernicova, I. et al. (2020). Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial. Lancet. 8 (4), pp. 278-291. [Online].